Piflufolastat F 18: Diagnostic First Approval

This article summarizes the milestones in the development of piflufolastat F 18 leading to this approval as a radioactive diagnostic agent in prostate cancer.
Source: Molecular Diagnosis and Therapy - Category: Molecular Biology Source Type: research